Spondyloenchondrodysplasia with immune dysregulation - CISMeF
Spondyloenchondrodysplasia with immune dysregulationOMIM Phenotype
Preferred Label : Spondyloenchondrodysplasia with immune dysregulation;
Symbol : SPENCDI;
CISMeF acronym : SPENCD; SPENCDI;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : SPENCD; Combined immunodeficiency with autoimmunity and spondylometaphyseal dysplasia; Roifman immunoskeletal syndrome;
Description : Spondyloenchondrodysplasia with immune dysregulation combines the typical metaphyseal
and vertebral bone lesions in spondyloenchondrodysplasia (SPENCD; 271550) with immune
dysfunction and neurologic involvement. The skeletal dysplasia is characterized by
radiolucent and irregular spondylar and metaphyseal lesions that represent islands
of chondroid tissue within bone. It has been suggested by some that the various clinical
manifestations observed in association with SPENCD may be pleiotropic manifestations
of a single nosologic entity defined by the presence of typical spondylar and metaphyseal
changes (summary by Renella et al., 2006).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the acid phosphatase 5, tartrate resistant gene (ACP5, 171640.0001);